# C2 — Owner Checklists: What Each Person Does Every Week

## CHARBEL (Product Lead — Workflow & UX)

| Week | Ongoing | Key Deliverables |
|---|---|---|
| **Every week** | | |
| | [ ] Update KR1.1a (epics deployed) in scorecard | |
| | [ ] Update KR1.1b (user count / companies) in scorecard | |
| | [ ] Report user activation numbers at daily BRA OKR Scoreboard (30 min) | |
| | [ ] Ensure demo environment is stable for sales calls | |
| | [ ] Attend Thu "Fixing" session (60 min) — credibility, noise, calibration | |
| **Wk 1-2** | | [ ] Assess demo-ability of BRA platform V1 (Y/N gate) |
| | | [ ] Identify top 3 UX blockers for workflow improvement |
| | | [ ] Platform usage instrumentation plan (for KR1.5e APM) |
| **Wk 3-4** | | [ ] Epic 2 deployed in Production |
| | | [ ] Post-demo feedback form created and deployed |
| | | [ ] UX modifications for disease-specific display (O2 KR2.3 support) |
| **Wk 5-6** | | [ ] Epic 3 deployed in Production |
| | | [ ] Demo environment stable for prospect demos |
| **Wk 7-8** | | [ ] Epic 4 deployed in Production |
| | | [ ] Account health scores calculated for all customers |
| **Wk 9-10** | | [ ] Epic 5 deployed in Production |
| | | [ ] Usage data compiled for expansion conversations |
| **Wk 11-12** | | [ ] All 5 epics deployed — KR1.1a target met |
| | | [ ] Full quarter product metrics compiled |
| | | [ ] Activation + retention data for board report |

---

## JEFF (CTO / Eng Lead — Reliability & Infra)

| Week | Ongoing | Key Deliverables |
|---|---|---|
| **Every week** | | |
| | [ ] Update KR1.5a (code coverage %) in scorecard | |
| | [ ] Update KR1.5b (critical/major bugs) in scorecard | |
| | [ ] Update KR1.5c (platform availability %) in scorecard | |
| | [ ] Update KR1.5d (ship time to Prod) in scorecard | |
| | [ ] Update KR1.5e (APM data coverage %) in scorecard | |
| | [ ] Monitor MLOps pipeline stability | |
| | [ ] Attend daily BRA OKR Scoreboard (30 min) | |
| **Wk 1-2** | | [ ] Baseline uptime, bug count, ship time, APM documented |
| | | [ ] SonarQube Quality Gate enforced on all deployments |
| | | [ ] Pipeline dashboard in CRM operational (support CEO) |
| | | [ ] APM instrumentation plan defined and started |
| **Wk 3-4** | | [ ] Performance benchmarks on real BRA cases documented |
| | | [ ] Ship time reduced toward 10 min target |
| | | [ ] Any enterprise security/compliance questions from deals → answered <48h |
| **Wk 5-6** | | [ ] Platform availability at 97%+ trailing 30 days |
| | | [ ] APM data at 50%+ coverage |
| | | [ ] On-prem readiness assessment (if enterprise deal requires) |
| **Wk 7-8** | | [ ] Platform availability at 99%+ trailing 30 days |
| | | [ ] 0 critical/major bugs in Prod |
| | | [ ] Support CEO with security/compliance for negotiation-stage deals |
| **Wk 9-10** | | [ ] Ship time at 10 min target |
| | | [ ] APM data at 100% coverage |
| **Wk 11-12** | | [ ] All KR1.5 targets met |
| | | [ ] Infrastructure metrics for board report |
| | | [ ] Capacity plan for next quarter based on deal volume |

---

## VASSILI (Clinical Lead / Medical Strategy)

| Week | Ongoing | Key Deliverables |
|---|---|---|
| **Every week** | | |
| | [ ] Update KR1.2 ("Context" completeness + human work) in scorecard | |
| | [ ] Update KR1.3 (B&R Assessment F1 scores + human work) in scorecard | |
| | [ ] Update KR2.1 (dataset generation progress) in scorecard | |
| | [ ] Update KR2.2 (validation progress — external, internal, LLM) in scorecard | |
| | [ ] Lead Thu "Fixing" session (60 min) — credibility, noise, calibration | |
| | [ ] Attend daily BRA OKR Scoreboard (30 min) | |
| | [ ] Available for sales demos (clinical Q&A) on 24h notice | |
| **Wk 1-2** | | [ ] Benchmark 10 therapeutic axes for business potential + platform fit (O2 KR2.1) |
| | | [ ] Select 2-3 therapeutic axes (2 main, 1 stretch) |
| | | [ ] Identify gaps in Quality and use case per output |
| | | [ ] Schedule first KOL contacts for external validation (O2 KR2.2) |
| | | [ ] Leverage KOL network for 2+ warm intros to pharma contacts |
| **Wk 3-4** | | [ ] Gap analysis + action plan completed for selected axes |
| | | [ ] "Context" step — Alt. T. options at 50%+ completeness |
| | | [ ] Internal validation: test datasets generated (O2 KR2.2) |
| | | [ ] Clinical positioning language for one-pager |
| **Wk 5-6** | | [ ] Dataset 1 structuring in progress — 50%+ complete |
| | | [ ] "Context" completeness at 75%+ |
| | | [ ] B&R Assessment F1 scores at 60%+ |
| | | [ ] 2+ KOL interview sessions completed (external validation) |
| | | [ ] Reference story v1: clinical outcome data for sales use |
| **Wk 7-8** | | [ ] Dataset 1 structured — KR2.1 first axis complete |
| | | [ ] "Context" at >= 90% completeness (KR1.2 target) |
| | | [ ] B&R Assessment F1 at >= 85% (KR1.3 target) |
| | | [ ] External validation: 2+ outputs validated |
| | | [ ] LLM validation: test prompts created + validated |
| **Wk 9-10** | | [ ] Dataset 2 structured — KR2.1 target met |
| | | [ ] Internal validation: 4 outputs validated (KR2.2 target) |
| | | [ ] LLM validation: 4 outputs validated (KR2.2 target) |
| | | [ ] Data Analysis V0 delivered (KR1.4 target) |
| **Wk 11-12** | | [ ] All validation documentation finalized |
| | | [ ] All datasets integrated in platform (KR2.3 — 100%) |
| | | [ ] 2 functional demos ready (KR2.3 target) |
| | | [ ] Validation + dataset performance data for board report |

---

## CEO

| Week | Ongoing | Key Deliverables |
|---|---|---|
| **Every week (non-negotiable)** | | |
| | [ ] 5+ outbound prospecting actions (emails, LinkedIn, calls) per day | |
| | [ ] Update pipeline tracker (B3) every Tuesday | |
| | [ ] Update revenue dashboard (B2) every Friday | |
| | [ ] Run deal review with team (B5 template) every Tuesday | |
| | [ ] Update forecast (Commit/Best Case/Upside) every Friday | |
| | [ ] Check pipeline coverage ratio — if <2x, cancel non-revenue meetings | |
| | [ ] 1 LinkedIn post on BRA / regulatory topics | |
| | [ ] Log CEO revenue hours (target: 12-15 hrs/week, minimum 10) | |
| **Wk 1-2** | | [ ] Build target account list: 50 accounts identified + researched |
| | | [ ] Finalize pricing sheet (3 tiers + add-ons) |
| | | [ ] Draft 3 outbound email sequences (cold, warm, re-engage) |
| | | [ ] Request warm intros: 2 per investor, 3 per advisor |
| | | [ ] Review all existing pipeline against new stage criteria |
| | | [ ] Pull existing customer usage data, identify expansion candidates |
| | | [ ] Implement deal review template (B5) |
| **Wk 3-4** | | [ ] Deliver 3-5 discovery calls |
| | | [ ] Deliver 2-3 demos (with Vassili for clinical content) |
| | | [ ] Send first proposal or pilot agreement |
| | | [ ] Pipeline: $500k+ qualified |
| | | [ ] Create one-pager per therapeutic area |
| | | [ ] Create pilot proposal template with success criteria |
| **Wk 5-6** | | [ ] Pipeline: $1.0M+ qualified |
| | | [ ] 2-3 proposals outstanding |
| | | [ ] First deal enters S5 (negotiation) |
| | | [ ] Initiate first expansion conversation with existing customer |
| | | [ ] Create "Why we win" competitive positioning doc |
| | | [ ] Reference story v1 drafted |
| **Wk 7-8** | | [ ] Close first new logo ($100k-$175k) |
| | | [ ] Pipeline: $1.2M+ (replenished after closes) |
| | | [ ] 2-3 more deals in S4/S5 |
| | | [ ] First expansion deal proposed |
| | | [ ] GTM bundle for Axis 1 finalized |
| | | [ ] Reference story v2 with quantified outcomes |
| **Wk 9-10** | | [ ] Close deals 2-3 (new logos) |
| | | [ ] Close first expansion deal |
| | | [ ] Pipeline: $1.5M+ (including next-quarter opps) |
| | | [ ] GTM bundle for Axis 2 finalized |
| | | [ ] ARR target: $350k-$400k cumulative |
| **Wk 11-12** | | [ ] Push every Commit-category deal to signature |
| | | [ ] Close remaining expansion deals |
| | | [ ] Target: $500k ARR achieved |
| | | [ ] Next-quarter pipeline: $500k+ qualified |
| | | [ ] Prepare board report: ARR, pipeline, unit economics |
| | | [ ] Document sales motion: what worked, what didn't |

*Extracted from ArcaScience OKR Execution Blueprint — Part C*
